Monday, July 13, 2020 11:56:38 AM
"Under the emergency declaration, IPIX only needs to have an approved application for investigational new drug in order to designate Brilicidan as a “covered countermeasure”.
THIS SHOULD BE STICKEYED:
IPIX will advance brilicidan for covid-19 under the declaration of national emergency. For the education of the posters here regarding how the gov works during a National Emergency please look up and read the following laws: National Emergency Act, Stafford Act ammendments of 2000, and 2006, and Project Bioshield Act PREP act. Together these four laws will guide the development of brilicidan for COVID-19. The PREP act is particularly important because its purpose is to make any action involving a “medical countermeasure” immune from any liability of federal or state law. Project Bioshield Act creates the concepts of a “medical countermeasure.” Here is a link to the PREP declaration posted to the Federal Register March 10:
https://www.phe.gov/Preparedness/legal/prepact/Pages/COVID19.aspx
Under the emergency declaration, IPIX only needs to have an approved application for investigational new drug in order to designate Brilicidan as a “covered countermeasure”. If B gets this designation then it can be prescribed as the gov sees fit to as many people as they want with no threat of any liability. In fact any injuries due to brilicidan would be covered by a fund established by the gov under the law (same as for vaccines). IPIX does not have to follow the normal sequence of events in order to get this drug into as many patients as possible. They only need to have the approved investigational new drug application to begin the process. Please read the executive order I linked then go re-read todays PR. Educate yourself with the law that is currently in effect.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM